首页 | 本学科首页   官方微博 | 高级检索  
     


Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised,double-blind,placebo-controlled phase 3 trial
Authors:Prof Michael Manns  Prof Patrick Marcellin  Prof Fred Poordad  Evaldo Stanislau Affonso de Araujo  Prof Maria Buti  Prof Yves Horsmans  Ewa Janczewska  Prof Federico Villamil  Jane Scott  Monika Peeters  Oliver Lenz  Sivi Ouwerkerk-Mahadevan  Guy De La Rosa  Ronald Kalmeijer  Rekha Sinha  Maria Beumont-Mauviel
Affiliation:1. Medizinische Hochschule Hannover, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany;2. Service d''Hépatologie, Hôpital Beaujon, University Paris-Diderot and INSERM CRB3, Clichy, France;3. Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA;4. LIM-47 Hospital das Clinicas of the University of São Paulo School of Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil;5. Hospital Vall d''Hebron and Ciberhed del Instituto Carlos III, Barcelona, Spain;6. Université Catholique de Louvain St Luc, Brussels, Belgium;g ID Clinic, Myslowice, Poland;h CIPREC, Buenos Aires, Argentina;i Janssen Global Services, High Wycombe, UK;j Janssen Infectious Diseases, Beerse, Belgium;k Janssen Research and Development, Beerse, Belgium;l Janssen Global Services, Titusville, NJ, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号